This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

CQT - Conneqt Health

Jump to new

System

Joined
27 June 2010
Posts
4,335
Reactions
368
AtCor Medical Holdings Limited (ACG) is an Australian developer and marketer of non-invasive technologies, SphygmoCor, and complementary services for the measurement and management of central blood pressure and arterial stiffness. The Company's manufacturing and R&D facilities are located in Australia, and it has a European representative office. Its products are sold through a network of national distributors worldwide.

http://www.atcormedical.com
 
Announcement that the company has secured another patent for its flagship product, this one covering the European market.
4th Quarter CF statement should be out in 10 days or so. The 3Q CF statement was pretty dismal but this one will be interesting to see if it was simply a matter of timing of receipts vs something more concerning...
 
Cash Flow out earlier than I expected and its looking good.
Receipts from customers now at $2.5m - a complete turnaround from the lackluster $1.7m last quarter...


Company is now forecasting maiden NPAT of $2.7-$2.9m...

I've got a long way to go in the tipping comp as a few others are smashing it this month, but who knows where this will run in the last 9 days of the month
 

NPAT included R&D tax concession and grants. Are these sustainable? If not the H2 NPAT was only ~$0.7-0.8m as H1 was already at $2.1m.

Still not bad for a small cap company with plenty of growth potential, but the headline looks better than it really is imo.
 
On June 18th, 2018, Atcor Medical Holdings Limited (ACG) changed its name and ASX code to Cardiex Limited (CDX).
 
Cardiex Limited starting to creep up recently.

CDX is taking a 7.5% stake in Blumio Inc, a developer of a wearable blood pressure sensor, for $600,000. CardieX and Blumio are currently in first stage trials in partnership with Macquarie University to determine key diagnostic outputs from the Blumio sensor.

This is from the announcement dated 19 June:

 
Another good call Greg …. CDX continues to rise today up another 17% to 0.041 cents as I type and it looks like Supply has left the building for the moment
 
@greggles is on to it.
It appeared in my BO scan today (31/08/18) and I like both the weekly and daily charts.
Wearable blood pressure sensor, now that sounds like a promising idea. Hypertension is a ninja assasin. We don't notice it until it strikes.
I think this company and it's business is worth more research over the week-end.

 
CardieX looks like it's about to test those previous highs of 4.7c from September last year.

Today CDX announced the execution of a co-marketing agreement between CardieX subsidiary and leading US telehealth services provider, inHealth Medical Services Inc, and Anthem, Inc, the largest health insurance company in the United States. The agreement provides for the co-promotion of inHealth's services and plans to Anthem's healthcare and health insurance networks in the United States and internationally.

The CDX share price has surged 25.71% today to 4.4c on the back of this morning's announcement. Volume is huge with around 27 million shares changing hands. This is starting to look like a potential breakout to me.

 
There was some selling into yesterday's close at 4 cents but today showed some stabilization on reasonable volume to open and close above yesterday's close ….. Its got a good feel about it.
 
CardieX up another 13.3% today to 5.1c. Volume remains good and there appears to be accumulation going on as buyers continue to absorb supply.

Watching with interest.

 
greggles said:
CardieX up another 13.3% today to 5.1c. Volume remains good and there appears to be accumulation going on as buyers continue to absorb supply.
Click to expand...
You called this one back in July 2018 Greg Well done!

Potentially onward and upward if it can break and hold above 5.3 ….. Tomorrow should tell us more however.
 

.
Announcing U.S. launch of the CONNEQT Pulse, the world’s most advanced personal arterial health monitor, as well as the launch of the CONNEQT App in both the App Store and Google Play Store.

Deliveries to customers of Pulse units for U.S. customer orders has now commenced following receipt of the first 3,000 units from manufacturing partner, Andon - with the remaining 5,000 units of the Company’s initial order currently in transit and due to arrive at the Company’s fulfilment facility shortly.

The Company is now in the process of executing on its sales strategy to convert the current waitlist customers into orders including multiple online marketing and sales programs as part of the broader U.S market launch.

The CONNEQT App, part of the digital ecosystem developed to support the Pulse, is also now live in the App Store and Google Play Store, and available for download in the USA.

Key features of the CONNEQT App include:
• A Digital Health Coach: providing actionable insights, motivational support, and interpretation of your data to help you navigate your heart health journey.
• Comprehensive Arterial Health Metrics: providing unparalleled views into your health with detailed metrics, trends, and reports.
• Guided Health Programs: designed to promote healthy lifestyle changes through educational content and actionable tasks that help you improve and maintain your cardiovascular health.
• Educational Health Content: a curated selection of articles and advice that support your health journey, empowering you to make informed decisions and stay proactive in managing your cardiovascular wellness.
• Personalized Health Cards: allowing you to monitor a range of health conditions with tailored insights into heart, arterial, and brain health.
• Device and Screen Customization: giving you the ability to adjust your device display and screen configuration to prioritize the data you value most, ensuring you always have the most relevant information at your fingertips.
• Healthcare Professional Sharing: enabling users to confidentially share reports and other information with their primary care physicians.
 
On September 23rd, 2025, Cardiex Limited (CDX) changed its name and ASX code to Conneqt Health Limited (CQT).
 
You must log in or register to reply here.
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...